# New glioblastoma vaccine shows promising results in phase Ib clinical trial

**URL:** <https://archive.menshealtharchive.com/t/new-glioblastoma-vaccine-shows-promising-results-in-phase-ib-clinical-trial/2157>\
**Category:** Research Database\
**Created:** [April 1, 2019, 7:46pm UTC](https://archive.menshealtharchive.com/t/new-glioblastoma-vaccine-shows-promising-results-in-phase-ib-clinical-trial/2157 "2019-04-01T19:46:12Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![Science\_Daily](https://yyz1.discourse-cdn.com/flex035/user_avatar/archive.menshealtharchive.com/science_daily/32/325_2.png) [@Science\_Daily](https://archive.menshealtharchive.com/u/Science_Daily)\
**Post date:** [April 1, 2019, 7:46pm UTC](https://archive.menshealtharchive.com/t/new-glioblastoma-vaccine-shows-promising-results-in-phase-ib-clinical-trial/2157/1 "2019-04-01T19:46:13Z")

</div>

> **[New glioblastoma vaccine shows promising results in phase Ib clinical trial:...](https://www.sciencedaily.com/releases/2019/03/190331192548.htm)**
>
> A brain-cancer vaccine more than 20 years in the making suspends cancer growth in patients enrolled in early-stage trial.

  
A brain-cancer vaccine more than 20 years in the making suspends cancer growth in patients enrolled in early-stage trial.
